Simplicity Wealth,Llc Ventyx Biosciences, Inc. Transaction History
Simplicity Wealth,Llc
- $1.2 Billion
- Q1 2025
A detailed history of Simplicity Wealth,Llc transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Simplicity Wealth,Llc holds 12,127 shares of VTYX stock, worth $27,285. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,127Holding current value
$27,285% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding VTYX
# of Institutions
126Shares Held
45.4MCall Options Held
35.2KPut Options Held
40.6K-
Black Rock Inc. New York, NY4.77MShares$10.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.23MShares$9.53 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$7.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$6.98 Million0.23% of portfolio
-
Sio Capital Management, LLC New York, NY2.58MShares$5.81 Million1.12% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $127M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...